share_log

Tracon Pharmaceuticals | EFFECT: Others

SEC ·  Nov 4 19:04

Summary by Futu AI

Tracon Pharmaceuticals, Inc. has received a Notice of Effectiveness from the United States Securities and Exchange Commission (SEC) on November 1, 2024. The notice, identified by Accession Number 0000950170-24-119576 and Submission Type POS AM, signifies that the company's filing has been formally accepted by the SEC. The effectiveness of the filing, associated with File Number 333-224809, marks a significant regulatory milestone for Tracon Pharmaceuticals.
Tracon Pharmaceuticals, Inc. has received a Notice of Effectiveness from the United States Securities and Exchange Commission (SEC) on November 1, 2024. The notice, identified by Accession Number 0000950170-24-119576 and Submission Type POS AM, signifies that the company's filing has been formally accepted by the SEC. The effectiveness of the filing, associated with File Number 333-224809, marks a significant regulatory milestone for Tracon Pharmaceuticals.
Helpful
Not Helpful

This announcement is a separate document:

Doc 1

The information provided by Futu AI is automatically generated by third-party artificial intelligence (AI) software based on news content. It is only available to users located outside of China mainland.


The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
    Heat List
    US
    SymbolLatest Price% Chg

    No Data

    Hot News
    Updated